Generare Bioscience
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- $27M
Investors
- 8
About Generare Bioscience
Generare is a biotechnology company focused on discovering and producing natural chemicals made from microbial DNA. The company uses modern cloning techniques to accelerate the discovery of compounds that could be used to develop medications like antibiotics and cancer therapies. The firm is ffocused on the chemical variation found in microorganisms, the majority of which has yet to be discovered. Generare's mission is to fight antibiotic resistance while also benefiting society and the environment.
Who invested in Generare Bioscience
8 investors across 2 rounds
See all investors in Generare Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Generare Bioscience
Who invested in Generare Bioscience?
Generare Bioscience has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Generare Bioscience raised?
Generare Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Generare Bioscience last raise money?
Generare Bioscience's most recent round on record is a Series A, in Apr 2026.
What does Generare Bioscience do?
Generare is a biotechnology company focused on discovering and producing natural chemicals made from microbial DNA.
Where is Generare Bioscience headquartered?
Generare Bioscience is headquartered in Paris, France.
Which VCs invest in companies like Generare Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Generare Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Generare Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.